Medical Communications

Showing 15 posts of 6411 posts found.

Europe vs USA: New drug approvals

June 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs

Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …
european_commission_web

New biosimilar guidelines launched in the EU

June 1, 2017 Medical Communications, Research and Development, Sales and Marketing EMA, biosimilars

A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for …
pills_in_hand

Ohio takes legal action against pharma companies for opioid crisis

June 1, 2017 Medical Communications Ohio, opioid, opioid crisis

If there is one state that needs answers for its citizens’ struggles with opioids, it is Ohio. The state saw …

Navigating the challenges of health technology assessment

May 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …
joe-ciaffoni-biogen-750xx2574-1445-0-143

Collegium bring in former Biogen SVP as new COO

May 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Collegium pharmaceutical

Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …
shutterstock_46732501

Could robots solve the pharma talent crisis?

May 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …
valium_10mg_roche

Evidence of tampering with Valium medication in Australia

May 31, 2017 Medical Communications, Research and Development Roche, valium

Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …

Global Pricing Innovations and Pricing360 announce new strategic partnership

May 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …
dr

WHO elects first African Director General

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
pollution

Superbugs in the supply chain

May 26, 2017 Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs

Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …
dna

Furore over DNA testing company’s licensing of consumers’ data

May 26, 2017 Medical Communications 23andME, Ancestry, DNA, DNA testing, genetic information

A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …
breast_cancer

Puma Biotech’s breast cancer drug gets FDA committee nod

May 25, 2017 Medical Communications, Sales and Marketing Puma Biotech, breast cancer, neratinib

Puma Biotechnology breast cancer drug that could be used to reduce the risk of disease recurrence has been boosted by …
The Gateway to Local Adoption Series

Latest content